NCT05345236 A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD) Status COMPLETED Phase PHASE3
NCT05324774 Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema Status UNKNOWN Phase PHASE3
NCT05324592 Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema Status COMPLETED Phase PHASE1
NCT05126966 A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration Status WITHDRAWN Phase PHASE3
NCT05063734 A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. Status TERMINATED Phase PHASE2
NCT04964089 A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) Status COMPLETED Phase PHASE3
NCT04932980 Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD Status ACTIVE_NOT_RECRUITING Phase NA
NCT04919096 Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration Status WITHDRAWN Phase PHASE1
NCT04740931 A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion Status COMPLETED Phase PHASE3
NCT04740905 A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion Status COMPLETED Phase PHASE3
NCT04684394 A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration Status TERMINATED Phase PHASE2
NCT04662944 A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections Status COMPLETED Phase N/A
NCT04611152 A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) Status TERMINATED Phase PHASE3
NCT04603937 A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) Status TERMINATED Phase PHASE3
NCT04592419 A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) Status COMPLETED Phase PHASE3
NCT04567550 RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME) Status ACTIVE_NOT_RECRUITING Phase PHASE2